PPT-Hypertension Update: How Low Shall We Go?

Author : cheryl-pisano | Published Date : 2018-10-01

Claude K Lardinois MD FACP MACN FACE lardinoissbcglobalnet Emeritus Professor University of Nevada School of Medicine Reno Nevada Board Certified Endocrinologist

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Hypertension Update: How Low Shall We G..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Hypertension Update: How Low Shall We Go?: Transcript

Claude K Lardinois MD FACP MACN FACE lardinoissbcglobalnet Emeritus Professor University of Nevada School of Medicine Reno Nevada Board Certified Endocrinologist Medical Director for American Health Care Rocklin CA. Weber MD Ernesto L Schiffrin MD William B White MD Samuel Mann MD Lars H Lindholm MD John G Kenerson MD John M Flack MD Barry L Carter Pharm D Barry J Materson MD C Venkata S Ram MD 10 Debbie L Cohen MD 11 JeanClaude Cadet MD 12 Roger R JeanCharles CHAPTER Hypertension and the Kidney Adrenal Hypertension PHYSIOLOGIC MECHANISMS IN ADRENAL HYPERTENSION DisorderPrimary aldosteronismCushing Christian Delles. BHF Glasgow Cardiovascular Research . Centre. Institute of Cardiovascular and Medical Sciences. University of Glasgow. Cardiovascular Continuum. Twin studies, pedigree studies. BP variability attributable to all genetic factors: . ACCF/AHA 2011. Expert Consensus Document. . . Developed in collaboration with the American Academy of Neurology, Association of Black Cardiologists, American Geriatrics Society, American Society of Hypertension, American Society of Nephrology, American Society for Preventive Cardiology, and the European Society of Hypertension. Classification (. A. dults). BP Classification. Systolic BP (mmHg). Diastolic BP (mmHg). Normal. < 120. and <. 80. Prehypertension. 120 – 139. or 80 - 89. Stage 1 hypertension. Identify . differential diagnosis of a case presented with the . symptoms . of lower limb . oedema. .. Differentiate . between different etiologies of . hypertension.. Discuss . briefly between stages of hypertension.. Circulation 2014;129:587-597. Teaching Tool: Hyperfiltration Early Sign of Hypertension and Diabetes. J Am Soc Nephrol 2017;28:1023-1039. Hyperfiltration Early in . Diabetic Nephropathy. Circulation 2016;134:752-772. Jessica Schwenk, Pharm.D.. September 14, 2013. Objectives. Review pharmacologic treatment of hypertension, including drug combinations and management of hypertension with other disease states. Discuss updates in the use of antihypertensive drugs. Difinition. High blood pressure is defined as BP ≥140/90 millimeters of mercury (mmHg) as per JNC 8. Risk of hypertension. Hypertension is a major independent risk factor for coronary artery disease, stroke, heart failure, and renal failure. Hypertension . doubles the risk of cardiovascular diseases, including coronary heart disease (CHD), congestive heart failure (CHF), ischemic and hemorrhagic stroke, renal failure, and peripheral arterial disease. Samir Mustafa Smisim Medical Director Of training Dept SRCA, Saudi Arabia Abstract: Introduction: Gestational Hypertension can lead to a serious con - Preeclampsia,referredtoToxemia.Hyperten - sion d 2013 ESH-ESC Guidelines for the Management of Arterial Hypertension . 2013 ESH/ESC Hypertension Guidelines. Journal of Hypertension 2013. European Heart Journal 2013. Blood Pressure 2013. Levels of evidence. Peter Julian A. Francisco, MD, DFM. Clinical Associate Professor UPCM – Department of Family and Community Medicine. Professional Member, International Society of Hypertension. EPIDEMIOLOGY. The global prevalence of hypertension is high. In 2000 it is suggested that approximately 26 % of the total population had hypertension. (Kearney, PM et al. Lancet 2005).. Lead Speaker: Dr Tarek Antonios. Ambra Caruso, Kristina . Leonnet. and Dr Roy Jogiya. Today:. 2. Welcome and Reminders – Ambra Caruso. National Blood Pressure Programme – Kristina . Leonnet. Hypertension Webinar – Dr Tarek Antonios.

Download Document

Here is the link to download the presentation.
"Hypertension Update: How Low Shall We Go?"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.